SFTPD and idiopathic interstitial pneumonia: These include Krebs von den Lungen-6 protein (KL-6), which has been associated with a higher rate of disease progression in patients with IPF and CTD-ILDs [82–85], and surfactant protein-D (SP-D) [86, 87].